David Sinclair· PhD
I am very proud of the team at MetroBiotech, who have developed a stabilized, GMP grade, patented form of NMN & have taken it into multiple FDA-regulated clinical trials to treat major diseases.
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
I am very proud of the team at MetroBiotech, who have developed a stabilized, GMP grade, patented form of NMN & have taken it into multiple FDA-regulated clinical trials to treat major diseases.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Metrobiotech is also testing MIB-725, a non-supplement, superior molecule to NMN that is in human trials - and so far looks very promising
I am very proud of https://t.co/ebQPf2e6A1 who have over many years developed a stabilized, GMP grade, patented form of NMN & has taken this into multiple FDA-regulated clinical trials to treat major diseases - and with positive results…
Human clinical trials conducted by MetroBiotech on NMN have produced promising results, some of which are published (Pencina et al., 2022) and some are under peer review